| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/02/1996 | WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
| 05/02/1996 | WO1996012806A1 Calcineurin interacting protein compositions and methods |
| 05/02/1996 | WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 05/02/1996 | WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | WO1996012795A1 Cytoassay |
| 05/02/1996 | WO1996012788A1 Flavored malt beverages |
| 05/02/1996 | WO1996012736A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY |
| 05/02/1996 | WO1996012733A1 Major outer membrane protein cd of moraxella |
| 05/02/1996 | WO1996012697A2 Calcium receptor-active compounds |
| 05/02/1996 | WO1996012544A1 A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES |
| 05/02/1996 | WO1996012508A2 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 05/02/1996 | WO1996012507A1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| 05/02/1996 | WO1996012408A1 Reagents with enhanced performance in clinical diagnostic systems |
| 05/02/1996 | WO1996012397A2 Recombinant antibody capable of binding to pna/nucleic acid complexes |
| 05/02/1996 | WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor |
| 05/02/1996 | WO1996008211A3 Plasma grafting methods and compounds |
| 05/02/1996 | WO1996007100A3 Luciferase labelling method |
| 05/02/1996 | DE4438383A1 Drilling resistance measuring unit on drill with feed and rotary drive |
| 05/02/1996 | DE4438087A1 Sensor for detecting super-oxide anion |
| 05/02/1996 | DE4438077A1 Computerised oxygen measurement system for activated sludge plant |
| 05/02/1996 | DE4437970A1 Predicting consistency of concrete in transit |
| 05/02/1996 | DE4244708C2 Ascertaining type list for liquid sample examintion |
| 05/02/1996 | DE19500394A1 Peptide zur Diagnose, zum Nachweis und zur Prävention von Hepatitis C Virus (HCV)-Infektionen Peptides for diagnosis, for the detection and prevention of hepatitis C virus (HCV) infections |
| 05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | CA2203825A1 Compounds and methods for inhibiting beta-protein filament formation and neurotoxicity |
| 05/02/1996 | CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | CA2203098A1 Method for preparing a sample in a scan capillary for immunofluorescent interrogation |
| 05/02/1996 | CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | CA2202893A1 Reagents with enhanced performance in clinical diagnostic systems |
| 05/02/1996 | CA2202891A1 Composition use of nucleoside analogues and gene transfection for tissue imaging and thereapy |
| 05/02/1996 | CA2200427A1 Receptor for a bacillus thuringiensis toxin |
| 05/02/1996 | CA2184826A1 Direct fluorescence-conjugated immunoassay for platelet activation |
| 05/02/1996 | CA2161826A1 Method of measuring interferon activity |
| 05/01/1996 | EP0709814A1 Method and device for determining the moisture-content of construction material |
| 05/01/1996 | EP0709681A1 Kinetic turbidimetric method for measuring endotoxin or (1-3)-beta-D-glucan |
| 05/01/1996 | EP0709680A1 Magnetic particles with gelatin and immunoassay using the same |
| 05/01/1996 | EP0709679A1 Method and layer structure to determine a substance |
| 05/01/1996 | EP0709678A1 Immunoassay plate |
| 05/01/1996 | EP0709677A2 Hapten conjugates with bioluminescent label for use in competitive immunoassays |
| 05/01/1996 | EP0709676A2 Method for coupling antibody to latex substrate and its use in immunoassay |
| 05/01/1996 | EP0709675A2 Chromatogenous testing system for urinalysis |
| 05/01/1996 | EP0709674A2 Leukocyte classification reagent |
| 05/01/1996 | EP0709668A2 Apparatus and method for measuring concentrations of gas components |
| 05/01/1996 | EP0709667A2 Method of calibration for an apparatus for the measurement of cell object features |
| 05/01/1996 | EP0709666A1 Device for withdrawing a representative milk sample |
| 05/01/1996 | EP0709651A1 Process for controlling the relative positioning of patterns on a sheet of material |
| 05/01/1996 | EP0709468A1 A process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification, a diagnostic assay employing said process, a kit and a container suitable for carrying out said process or assay |
| 05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
| 05/01/1996 | EP0709455A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
| 05/01/1996 | EP0709396A1 Gamma T cell receptor and methods for detection |
| 05/01/1996 | EP0709138A2 Method and apparatus for determining the purity of recycled glass cullet |
| 05/01/1996 | EP0708924A1 Method and kit for the quantitative determination of human thyroid peroxidase |
| 05/01/1996 | EP0708923A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 05/01/1996 | EP0708922A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 05/01/1996 | EP0708921A1 Test device |
| 05/01/1996 | EP0708920A1 A method and apparatus for testing the thermal stability of an (aviation) fuel |
| 05/01/1996 | EP0708917A1 A method of measuring spalling of a protective surface |
| 05/01/1996 | EP0708841A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 05/01/1996 | EP0708837A1 Fluorescent polymer labeled conjugates and intermediates |
| 05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 05/01/1996 | EP0708784A1 COMPOUNDS HAVING THE ANTIGENICITY OF hCG |
| 05/01/1996 | EP0708767A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 05/01/1996 | EP0708751A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses |
| 05/01/1996 | EP0708653A1 Assay and reagents for identifying anti-proliferative agents |
| 05/01/1996 | EP0708649A1 Preparation and stabilisation of cells |
| 05/01/1996 | EP0708645A1 Use of compounds which inhibit phosphatidic acid formation for the manufacture of a medicament for the treatment of cancer |
| 05/01/1996 | EP0708615A1 Noninvasive glucose monitor |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | EP0708591A1 Low cholesterol eggs |
| 05/01/1996 | EP0643840A4 A method and system for sampling and determining the presence of compounds in containers. |
| 05/01/1996 | EP0586694B1 Process and device for low-emission spraying |
| 05/01/1996 | EP0543867B1 Method and apparatus for determination of chemical species in body fluid |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | CN2226307Y Auto-thermostat for measuring coagulation time by test tube method for clinical application |
| 05/01/1996 | CN1121746A Device for analyzing a fluid medium |
| 05/01/1996 | CN1121745A Device for analyzing a fluid medium |
| 05/01/1996 | CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof |
| 05/01/1996 | CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 04/30/1996 | US5513125 Process for determining the percentage of combustible gases in a gas mixture as well as their classification according to gas class factors |
| 04/30/1996 | US5512752 Method of determining type of plastics |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512659 Compositions useful in heterogeneous immunoassays |
| 04/30/1996 | US5512657 Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
| 04/30/1996 | US5512648 Polyamide resin-protide conjugate, preparation and uses |
| 04/30/1996 | US5512578 Administering bimodally-acting opioid agonist and excitatory opioid receptor antagonist |
| 04/30/1996 | US5512493 Coupling reagent with a donor compound consisting of a rare earth chelate or cryptate of terbium or europium; exciting with light source |
| 04/30/1996 | US5512492 Waveguide immunosensor with coating chemistry providing enhanced sensitivity |
| 04/30/1996 | US5512491 Method for ultra-trace level analysis of water |
| 04/30/1996 | US5512489 Laser photoablation of dielectric material to expose electrically conducting material and form electrode |
| 04/30/1996 | US5512488 Colorimetric assay for bioactive polysaccharide |
| 04/30/1996 | US5512486 Single step signal group-imidazole labeling of organic phosphate groups under aqueous conditions |
| 04/30/1996 | US5512485 Process control |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512453 Activated killer monocytes and tumoricidal activity and pharmaceutical compositions |
| 04/30/1996 | US5512450 Test device for determining the presence of leukocyte cells, esterase or protease in a test sample |
| 04/30/1996 | US5512449 Method for the functional determination of protein C inhibitor |
| 04/30/1996 | US5512448 Polyethylene oxide or polyvinyl alcohol |
| 04/30/1996 | US5512447 Methods for the diagnosis and treatment of diabetes |